Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06UWF
|
||||
Former ID |
DIB001115
|
||||
Drug Name |
SOR-C13
|
||||
Indication | Ovarian cancer [ICD9: 183; ICD10:C56] | Phase 1 | [523872] | ||
Company |
Soricimed biopharma
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Transient receptor potential channel 6, subfamily V | Target Info | Inhibitor | [532294] | |
KEGG Pathway | Salivary secretion | ||||
Mineral absorption | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | TCR signaling in naï | ||||
Signaling events mediated by PTP1B | |||||
TCR signaling in naï | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.